Last reviewed · How we verify

NCT04537390: AMH

Anti-mullerian Hormone Levels in Healthy Females

Recruiting now NA Last updated 18 November 2024
What this trial tests

NA trial testing Blood sample collection in Healthy in 100 participants. Currently enrolling.

Timeline
19 July 2016
Primary endpoint
1 December 2030
1 December 2030

Quick facts

Lead sponsorErin Rowell
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date19 July 2016
Primary completion1 December 2030
Estimated completion1 December 2030
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Erin Rowell

Who can join

Under 18, female only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood sample collection

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Erin Rowell trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04537390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing